Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :5880
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded389    
    Comments [Add]    
    Cited by others 1    

Recommend this journal


Year : 2015  |  Volume : 52  |  Issue : 3  |  Page : 425-428

Neuropathic pain in cancer patients: A brief review

1 Department of Anesthesiology and Pain Medicine, Henry Ford Hospital, Detroit, USA
2 Department of Neurology, Henry Ford Hospital, Detroit, USA

Correspondence Address:
V Loomba
Department of Anesthesiology and Pain Medicine, Henry Ford Hospital, Detroit
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0019-509X.176758

Rights and Permissions

Neuropathic pain (NP) is initiated or caused by a primary lesion or dysfunction in the nervous system. The NP in cancer patients is typically due to a combination of inflammatory, neuropathic, ischemic, infiltrative, and compression mechanisms that involve one or more anatomic sites. These patients will often have various types of co-existing pain syndromes and co-morbidities. Thus, any treatment plan needs to be individualized. After a thorough clinical assessment and evaluation, a combination therapy including anticonvulsants, antidepressants, N-methyl-D-aspartate antagonists, opiates, topical agents, and interventional procedures should be considered in these patients.


Print this article     Email this article

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow